We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
401
Teledyne Technologies
TDY
$28.3B
$2.4M 0.02%
+3,605
New +$2.27M
NHI icon
402
National Health Investors
NHI
$3.48B
$2.34M 0.02%
30,673
-227,350
-88% -$17.4M
FCN icon
403
FTI Consulting
FCN
$4.19B
$2.33M 0.01%
+15,621
New +$2.56M
NLY icon
404
Annaly Capital Management
NLY
$17.2B
$2.32M 0.01%
+103,892
New +$2.29M
MAA icon
405
Mid-America Apartment Communities
MAA
$14.9B
$2.32M 0.01%
16,693
-98,679
-86% -$12.9M
CMCSA icon
406
Comcast
CMCSA
$94B
$2.3M 0.01%
93,705
-15,024
-14% -$388K
UHS icon
407
Universal Health Services
UHS
$10B
$2.29M 0.01%
+15,397
New +$2.5M
MMS icon
408
Maximus
MMS
$3.02B
$2.22M 0.01%
41,332
+32,359
+361% +$2.02M
LNT icon
409
Alliant Energy
LNT
$17.6B
$2.21M 0.01%
28,987
-135,610
-82% -$9.88M
AGNC icon
410
AGNC Investment
AGNC
$12.6B
$2.2M 0.01%
+201,433
New +$2.12M
FDS icon
411
Factset
FDS
$10.7B
$2.18M 0.01%
+9,470
New +$2.17M
BC icon
412
Brunswick
BC
$4.82B
$2.16M 0.01%
25,623
+625
+3% +$50.1K
CCI icon
413
Crown Castle
CCI
$32.3B
$2.14M 0.01%
28,241
+12,759
+82% +$1.12M
MZTI
414
The Marzetti Company
MZTI
$2.88B
$2.13M 0.01%
18,693
+3,138
+20% +$377K
ORKA
415
Oruka Therapeutics
ORKA
$6.13B
$2.13M 0.01%
+22,421
New +$1.49M
KEX icon
416
Kirby Corp
KEX
$7.43B
$2.1M 0.01%
15,480
+15,458
+70,264% +$2.21M
TNL icon
417
Travel + Leisure Co
TNL
$4.06B
$2.08M 0.01%
27,199
+824
+3% +$57.9K
EXPO icon
418
Exponent
EXPO
$3.25B
$2.08M 0.01%
35,346
+23,421
+196% +$1.44M
ARXS
419
Arxis Inc
ARXS
$23.1B
$2.08M 0.01%
+45,000
New +$1.76M
KLIC icon
420
Kulicke & Soffa
KLIC
$4.27B
$2.03M 0.01%
15,201
+7,544
+99% +$739K
SYRE icon
421
Spyre Therapeutics
SYRE
$7.85B
$2.02M 0.01%
+22,777
New +$1.66M
WGO icon
422
Winnebago Industries
WGO
$877M
$2.02M 0.01%
64,671
+52,133
+416% +$1.59M
RS icon
423
Reliance Steel & Aluminium
RS
$20.4B
$2M 0.01%
5,357
+1,574
+42% +$575K
WST icon
424
West Pharmaceutical
WST
$23.9B
$2M 0.01%
5,570
+5,478
+5,954% +$1.67M
WLK icon
425
Westlake Corp
WLK
$9.56B
$1.99M 0.01%
+27,248
New +$2.66M

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.